HTA Quarterly Archive

HTA Quarterly

Summer 2018

We take a look at whether value frameworks are the path to implementing value-based pricing, the EMA's move out of the United Kingdom, and look at the health policy trends in Canada from InnomarLive.
Read issue

HTA Quarterly 

Spring 2018

We examine oncology appraisal differences between NICE and SMC, market access for cell and gene therapies, and managed entry agreements.
Read issue

HTA QUarterly

Late Summer 2017

We examine medical nutrition reimbursement, severe asthma therapies, and brazil's healthcare market.
Read issue

HTA QUARTERLY

Summer 2017

We take a look at patient input into HTA decisions in 4 countries, examining new therapies for Duchenne Muscular Dystrophy, and understanding the Colombian universal healthcare model.
Read issue

Our Editors

EDITOR-IN-CHIEF

Trent McLaughlin, Ph.D.

Vice President, Global Health Economics and Outcomes Research
Meet Dr. McLaughlin

MANAGING EDITOR

Kellie Meyer, PharmD, MPH

Senior Director, Global Health Economics & Outcomes Research (GHEOR) 
Meet Dr. Meyer

Editorial Board

  • Josep Darba, PhD Professor | Department of Economics | University of Barcelona
  • George Papadopoulos, BSc(Hons), GradDipEpi President | Emerald Corporate Group
  • Ken Redekop, BSc, MPH, PhD Visiting Associate Professor | National University of Singapore
  • Eldon Spackman, BA, MA, PhD Co-Director | Institute for Public Health | University of Calgary
  • Keith Tolley Director | Tolley Health Economics
  • Thomas Mittendorf, MSc, PhD Managing Director | Xcenda GmbH
  • Michael Eaddy, PharmD, PhD Vice President, Scientific Consulting | Xcenda
  • Jay Jackson, PharmD, MPH Senior Vice President, Consulting Services | Xcenda